2-(3,6-dioxo-1H-pyridazin-2-yl)-N-(3-hydroxy-2,2-dimethylpropyl)acetamide

C11H17N3O4 — CID 113294515

IUPAC2-(3,6-dioxo-1H-pyridazin-2-yl)-N-(3-hydroxy-2,2-dimethylpropyl)acetamide
SMILESCC(C)(CO)CNC(=O)Cn1[nH]c(=O)ccc1=O
InChIInChI=1S/C11H17N3O4/c1-11(2,7-15)6-12-9(17)5-14-10(18)4-3-8(16)13-14/h3-4,15H,5-7H2,1-2H3,(H,12,17)(H,13,16)
InChIKeyURGAWKZQDBYFRF-UHFFFAOYSA-N
MW255.27 g/mol
LogP-1.33
Rot. Bonds5

About 2-(3,6-dioxo-1H-pyridazin-2-yl)-N-(3-hydroxy-2,2-dimethylpropyl)acetamide

2-(3,6-dioxo-1H-pyridazin-2-yl)-N-(3-hydroxy-2,2-dimethylpropyl)acetamide (PubChem CID 113294515) has the molecular formula C11H17N3O4 and a molecular weight of 255.27 g/mol. Its IUPAC name is 2-(3,6-dioxo-1H-pyridazin-2-yl)-N-(3-hydroxy-2,2-dimethylpropyl)acetamide.

Molecular Properties

Compound Name2-(3,6-dioxo-1H-pyridazin-2-yl)-N-(3-hydroxy-2,2-dimethylpropyl)acetamide
PubChem CID113294515
Molecular FormulaC11H17N3O4
Molecular Weight255.27 g/mol
Exact Mass255.12
IUPAC Name2-(3,6-dioxo-1H-pyridazin-2-yl)-N-(3-hydroxy-2,2-dimethylpropyl)acetamide
SMILESCC(C)(CO)CNC(=O)Cn1[nH]c(=O)ccc1=O
InChIInChI=1S/C11H17N3O4/c1-11(2,7-15)6-12-9(17)5-14-10(18)4-3-8(16)13-14/h3-4,15H,5-7H2,1-2H3,(H,12,17)(H,13,16)
InChIKeyURGAWKZQDBYFRF-UHFFFAOYSA-N
XLogP-1.33
TPSA104.19 Ų
H-Bond Donors3
H-Bond Acceptors5
Rotatable Bonds5
Heavy Atoms18
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500255.27
LogP ≤ 5-1.33
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 105

Analyze 2-(3,6-dioxo-1H-pyridazin-2-yl)-N-(3-hydroxy-2,2-dimethylpropyl)acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-(2,2-difluoro-3-hydroxypropyl)-2-(3,6-dioxo-1H-pyridazin-2-yl)acetamide
CID 104857459
2-(3,6-dioxo-1H-pyridazin-2-yl)-N-(2-hydroxyethyl)acetamide
CID 43388954
2-(3,6-dioxo-1H-pyridazin-2-yl)-N-(3-hydroxypropyl)acetamide
CID 43500367
2-(3,6-dioxo-1H-pyridazin-2-yl)-N-(1-hydroxybutan-2-yl)acetamide
CID 43500440
2-(3,6-dioxo-1H-pyridazin-2-yl)-N-(1-hydroxy-2-methylpropan-2-yl)acetamide
CID 43500745
2-(3,6-dioxo-1H-pyridazin-2-yl)-N-(1-hydroxypropan-2-yl)acetamide
CID 43501076
2-(3,6-dioxo-1H-pyridazin-2-yl)-N-(2-hydroxypropyl)acetamide
CID 43501159
2-(3,6-dioxo-1H-pyridazin-2-yl)-N-(3-hydroxypropyl)-N-propan-2-ylacetamide
CID 54917536
2-(3,6-dioxo-1H-pyridazin-2-yl)-N-[3-(hydroxymethyl)pentan-3-yl]acetamide
CID 55082397
2-(3,6-dioxo-1H-pyridazin-2-yl)-N-(2-hydroxyethyl)-N-propylacetamide
CID 61425344
N-butyl-2-(3,6-dioxo-1H-pyridazin-2-yl)-N-(2-hydroxyethyl)acetamide
CID 61448247
2-(3,6-dioxo-1H-pyridazin-2-yl)-N-(1-hydroxy-2-methylbutan-2-yl)acetamide
CID 64555582

Frequently Asked Questions

What is the IUPAC name of 2-(3,6-dioxo-1H-pyridazin-2-yl)-N-(3-hydroxy-2,2-dimethylpropyl)acetamide?
The IUPAC name of 2-(3,6-dioxo-1H-pyridazin-2-yl)-N-(3-hydroxy-2,2-dimethylpropyl)acetamide (CID 113294515) is 2-(3,6-dioxo-1H-pyridazin-2-yl)-N-(3-hydroxy-2,2-dimethylpropyl)acetamide.
What is the SMILES notation for 2-(3,6-dioxo-1H-pyridazin-2-yl)-N-(3-hydroxy-2,2-dimethylpropyl)acetamide?
The canonical SMILES for 2-(3,6-dioxo-1H-pyridazin-2-yl)-N-(3-hydroxy-2,2-dimethylpropyl)acetamide is CC(C)(CO)CNC(=O)Cn1[nH]c(=O)ccc1=O.
What is the InChIKey of 2-(3,6-dioxo-1H-pyridazin-2-yl)-N-(3-hydroxy-2,2-dimethylpropyl)acetamide?
The InChIKey is URGAWKZQDBYFRF-UHFFFAOYSA-N. The full InChI is InChI=1S/C11H17N3O4/c1-11(2,7-15)6-12-9(17)5-14-10(18)4-3-8(16)13-14/h3-4,15H,5-7H2,1-2H3,(H,12,17)(H,13,16).
What are the key properties of 2-(3,6-dioxo-1H-pyridazin-2-yl)-N-(3-hydroxy-2,2-dimethylpropyl)acetamide?
2-(3,6-dioxo-1H-pyridazin-2-yl)-N-(3-hydroxy-2,2-dimethylpropyl)acetamide has a molecular weight of 255.27 g/mol, XLogP of -1.33, 5 rotatable bonds, 3 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(3,6-dioxo-1H-pyridazin-2-yl)-N-(3-hydroxy-2,2-dimethylpropyl)acetamide is sourced from PubChem (CID 113294515), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).